对于急性心肌梗塞中能量代谢的新兴治疗策略
Ruixin Ma1,2,3,4,5, Dazhou Lu1,2,3,4,5, Zeyu Yang1,2,3,4,5
1Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, 250012, China.
Journal of translational medicine
|October 22, 2025
概括
急性心肌梗塞 (AMI) 通过破坏能量代谢引发心脏细胞损伤. 针对新陈代谢重编程和线粒体功能的治疗显示出治疗缺血症再输液损伤 (IRI) 和改善结果的希望.
科学领域:
- 心血管医学 心血管医学
- 细胞的新陈代谢
- 生物化学 生物化学
背景情况:
- 急性心肌梗塞 (AMI) 导致不可逆转的心肌细胞损伤由于缺血和缺氧.
- 缺血-再输液损伤 (IRI) 加剧了后AMI的心律失常和心力衰竭等并发症.
- 在AMI和IRI期间,心肌能量代谢受到严重干扰.
研究的目的:
- 审查心肌能代谢在AMI病变发生中的作用.
- 为了探索细胞损伤在缺血-再输液过程中的机制.
- 讨论新兴的治疗策略,以减轻IRI.
主要方法:
- 综合临床前和临床证据的文献综述.
- 专注于脂肪酸氧化,糖解和线粒体功能的失调.
- 关键损伤机制的分析:ROS过度生产,酸盐积累,mPTP开放.
主要成果:
- AMI破坏心肌能量代谢,影响FAO,糖解和线粒体功能.
- ROS,酸盐积累和mPTP开放是IRI的关键驱动因素.
- 代谢重编程,线粒体保护和缺血症调节是有前途的治疗途径.
结论:
- 代谢调节是缓解AMI中的IRI的一个重要方法.
- 针对细胞能量通路提供了改善患者治疗结果的潜力.
- 对AMI治疗的代谢干预措施进行进一步的研究是有必要的.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
216
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
216
Acute Coronary Syndrome V: Nursing Management
265
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
265
Acute Coronary Syndrome I: Introduction
794
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
794
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
351
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
351
Angina IV: Management
235
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
235
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319


